Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Equity Ratio (2017 - 2021)

Historic Equity Ratio for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to 0.92.

  • Cogent Biosciences' Equity Ratio rose 67763.79% to 0.92 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.92, marking a year-over-year increase of 67763.79%. This contributed to the annual value of 0.94 for FY2020, which is 4552.75% up from last year.
  • Cogent Biosciences' Equity Ratio amounted to 0.92 in Q3 2021, which was up 67763.79% from 0.93 recorded in Q2 2021.
  • Cogent Biosciences' 5-year Equity Ratio high stood at 0.95 for Q1 2021, and its period low was 1.41 during Q1 2018.
  • In the last 5 years, Cogent Biosciences' Equity Ratio had a median value of 0.65 in 2020 and averaged 0.43.
  • In the last 5 years, Cogent Biosciences' Equity Ratio tumbled by 13206.0% in 2020 and then surged by 67763.79% in 2021.
  • Cogent Biosciences' Equity Ratio (Quarter) stood at 0.99 in 2017, then skyrocketed by 170.49% to 0.7 in 2018, then decreased by 8.32% to 0.64 in 2019, then surged by 45.53% to 0.94 in 2020, then decreased by 2.08% to 0.92 in 2021.
  • Its Equity Ratio stands at 0.92 for Q3 2021, versus 0.93 for Q2 2021 and 0.95 for Q1 2021.